Novartis

Novartis is a prominent multinational pharmaceutical company based in Basel, Switzerland. Formed in 1996 from the merger of Ciba-Geigy and Sandoz Laboratories, it has a rich history in chemical and dye manufacturing that has evolved into pharmaceutical innovation over more than 250 years. The company operates in approximately 155 countries and is publicly traded on the SIX Swiss Exchange and the New York Stock Exchange.

Novartis develops, manufactures, and markets a wide range of prescription medicines, focusing on key therapeutic areas such as cardiovascular, renal, metabolic diseases, immunology, neuroscience, respiratory conditions, and oncology. The company emphasizes innovative therapies, including gene therapies and advanced biologics. Notable marketed drugs include Cosentyx for psoriasis, Entresto for heart failure, and Kymriah for certain leukemias. With a strong commitment to research, Novartis operates research institutes to drive innovation and enhance its product pipeline.